Patents by Inventor Willy Min Jou

Willy Min Jou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7993652
    Abstract: The present invention relates to an influenza antigen, comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein or a functional fragment thereof and a presenting carrier, which may be a presenting (poly)peptide or a non-peptidic structure, such as glycans, peptide mimetics, synthetic polymers. The invention further relates to a vaccine against influenza, comprising at least an antigen of the invention, optionally in the presence of one or more excipients. The invention also relates to use of the antigen, a method for preparing the antigen and acceptor cells expressing the antigen.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: August 9, 2011
    Assignee: FVlaams Interuniversitair Instituut Voors Biotechnologie
    Inventors: Sabine Neirynck, Willy Min Jou, Walter Fiers
  • Publication number: 20100297161
    Abstract: The present invention relates to an influenza antigen, comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein or a functional fragment thereof and a presenting carrier, which may be a presenting (poly)peptide or a non-peptidic structure, such as glycans, peptide mimetics, synthetic polymers. The invention further relates to a vaccine against influenza, comprising at least an antigen of the invention, optionally in the presence of one or more excipients. The invention also relates to use of the antigen, a method for preparing the antigen and acceptor cells expressing the antigen.
    Type: Application
    Filed: June 7, 2010
    Publication date: November 25, 2010
    Inventors: SABINE NEIRYNCK, WILLY MIN JOU, WALTER FIERS
  • Patent number: 7731972
    Abstract: The present invention relates to an influenza antigen, comprising a fusion product of at least (1) the extracellular part of a conserved influenza membrane protein (e.g., M2) or a functional equivalent thereof and (2) a presenting carrier. The presenting carrier may be a (poly)peptide or a non-peptidic structure such as glycans, peptide mimetics, and synthetic polymers. The invention further relates to methods of making and using the antigen, and to influenza vaccines comprising the antigen and optionally one or more excipients.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: June 8, 2010
    Assignee: Vlaams Interuniversitair Instituut Voor Biotechnologie
    Inventors: Sabine Neirynck, Willy Min Jou, Walter Fiers
  • Patent number: 7732130
    Abstract: The present invention relates to an influenza antigen, comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein or a functional fragment thereof and a presenting carrier, which may be a presenting (poly)peptide or a non-peptidic structure, such as glycans, peptide mimetics, synthetic polymers. The invention further relates to a vaccine against influenza, comprising at least an antigen of the invention, optionally in the presence of one or more excipients. The invention also relates to use of the antigen, a method for preparing the antigen and acceptor cells expressing the antigen.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: June 8, 2010
    Assignee: Vlaams Interuniversitair Instituut Voor Biotechnolgoie
    Inventors: Sabine Neirynck, Willy Min Jou, Walter Fiers
  • Publication number: 20060246092
    Abstract: The present invention relates to an influenza antigen, comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein or a functional fragment thereof and a presenting carrier, which may be a presenting (poly)peptide or a non-peptidic structure, such as glycans, peptide mimetics, synthetic polymers. The invention further relates to a vaccine against influenza, comprising at least an antigen of the invention, optionally in the presence of one or more excipients. The invention also relates to use of the antigen, a method for preparing the antigen and acceptor cells expressing the antigen.
    Type: Application
    Filed: March 14, 2006
    Publication date: November 2, 2006
    Applicant: Vlaams Interuniversitair Instituut Voor Biotechnologie
    Inventors: Sabine Neirynck, Willy Min Jou, Walter Fiers